J.R. Frost, C.B. Cheong, W.M. Akhtar et al.
Tetrahedron 86 (2021) 132051
combinations thereof. Coupling constants and DAB are quoted in Hz
to the nearest 0.1 Hz. Fourier-transform infrared (FT-IR) spectra
were recorded from evaporated films on a Bruker Tensor 27 spec-
trometer equipped with a Pike Miracle Attenuated Total Reflec-
tance (ATR) sampling accessory. Absorption maxima are quoted in
wavenumbers (nmax) with units of cmꢂ1 and for the range of
3600e600 cmꢂ1. High resolution mass spectrometry (HRMS) under
ESI conditions were recorded on a Thermo Exactive Orbitrap mass
spectrometer equipped with a Waters Equity LC system, a Bruker
MicroToF mass spectrometer equipped with an Agilent 1100 HPLC
pump and autosampler, or on a Waters Xevo Quadrupole Time of
Flight (Q-ToF) mass spectrometer. The Thermo Exactive system
employs a flow rate of 0.2 mL minꢂ1 using H2O:MeOH:HCOOH
(10:89.9:0.1) as eluent, with a heated electrospray ionisation (HESI-
II) probe and has a resolution of 50,000 FWHM. The Bruker system
uses the built-in electrospray source, while the Waters system runs
on a lock-mass mode with ESI performed by a secondary electro-
spray source, both using conditions identical to the Thermo Exac-
tive system. Instrument control and data processing were
performed using the softwares Thermo Xcalibur for the Thermo
Exactive system, Compass DataAnalysis 4.0 for the Bruker system,
and MassLynx for the Waters system. Unless otherwise specified,
the mass reported for HRMS is the mass-to-charge ratio containing
the most abundant isotopes, with each value to 4 or 5 decimal
places and within 5 ppm of the calculated mass. Single crystal X-ray
diffraction was performed with a (Rigaku) Oxford Diffraction
2 ꢃ CH2CHCO), 29.9 (2C, 2 ꢃ CH2CH2CH3), 23.0 (2C, 2 ꢃ CH2CH3),
19.5 (cyclopropyl CH), 14.1 (2C, 2 ꢃ CH3), 10.8 (2C, cyclopropyl
CAH2CH and cyclopropyl CBH2CH); HRMS (ESIþ) Found
[MþH]þ ¼ 197.1901; C13H25O requires 197.1900,
D 0.75 ppm.
4.3. Representative procedure for a-alkylation of aromatic ketones:
synthesis of 2-(cyclopropylmethyl)-1-mesitylhexan-1-one (49)
To a 2e5 mL Biotage® microwave vial equipped with a stirrer
bar was added 1-mesitylhexan-1-one (50.5 mg, 0.23 mmol),
[Ir(cod)Cl]2 (1.54 mg, 1 mol%), dppBz (2.1 mg, 2 mol%), KOH
(25.8 mg, 0.46 mmol) and cyclopropylmethanol (0.19 mL,
2.30 mmol) sequentially in the open atmosphere. The reaction
vessel was sealed with a microwave vial cap (containing a Reseal™
septum) and purged with Ar for 5 min using a balloon. Following
this, the vial (complete with an Ar balloon) was heated to 85 ꢀC in a
preheated oil bath for 24 h. The mixture was cooled to RT, filtered
through a SiO2 plug (eluting with Et2O) and concentrated in vacuo.
Purification by column chromatography (SiO2, eluent load, Penta-
ne:Et2O, 99:1 / 98:2) afforded the title compound 49 (54.1 mg,
86%) as a colorless oil. Rf ¼ 0.59 (Pentane:Et2O, 95:5), [UV, KMnO4];
IR (film) nmax/cmꢂ1 2955, 2929, 2859, 1689, 1611, 1571, 1457, 1428,
1378, 1355, 1305, 1297, 1274, 1240, 1231, 1212, 1160, 1133, 1103, 1077,
1034, 1016, 981; 1H NMR (CDCl3, 400 MHz)
d
¼ 6.83 (2H, s, 2 ꢃ Ar-
CH), 2.99 (1H, app. quint., J ¼ 6.4 Hz, CHCO), 2.27 (3H, s, Ar-CH3),
2.23 (6H, s, 2 ꢃ Ar-CH3), 1.76e1.66 (2H, m, CHAHBCHCO and
CHCHAHBCHCO), 1.53e1.43 (1H, m, CHAHBCHCO), 1.37e1.23 (5H, m,
CHCHAHBCHCO, CH2CH2CH3 and CH2CH3), 0.86 (3H, t, J ¼ 7.2 Hz,
CH3), 0.83e0.71 (1H, m, cyclopropyl CH), 0.47e0.41 (2H, m,
2 ꢃ cyclopropyl CHAHB), 0.08e0.02 (2H, m, 2 ꢃ cyclopropyl CHAHB);
Supernovae A diffractometer using Cu-K
a
radiation (
l
¼ 1.54184 Å)
and graphite monochromator. Samples were mounted in
a
perfluoropoly-ethyl ether oil and cooled by a Cryostream N2 open-
flow cooling device to 150 K throughout the data collection process.
The diffraction patterns were integrated and reduced using the
software CrysAlisPro. The software CRYSTALS for Microsoft Win-
dows was used to obtain ab initio solutions using SuperFlip [27]
embedded within CRYSTALS [28] and to carry out structure
refinement. Melting points (m.p.) were obtained using a Leica
VMTG heated-stage microscope equipped with a Testo 720 ther-
mometer and are uncorrected.
13C NMR (CDCl3, 101 MHz)
d
¼ 212.7 (C]O), 138.9 (AreC), 138.5
(AreC), 133.9 (2C, 2 ꢃ AreC), 130.0 (2C, 2 ꢃ Ar-CH), 53.6 (CHCO),
34.7 (CHCH2CHCO), 29.9 (CH2CHCO), 29.7 (CH2CH2CH3), 23.0
(CH2CH3), 21.2 (Ar-CH3), 20.0 (2C, 2 ꢃ Ar-CH3), 14.1 (CH3), 9.7
(cyclopropyl CH), 5.4 (cyclopropyl CAH2), 5.3 (cyclopropyl CBH2);
HRMS (ESIþ) Found [MþH]þ ¼ 273.22125; C19H29O requires
273.22129,
D 0.15 ppm.
Detailed experimental procedures, characterization data and
NMR spectra for all novel alcohols, substrates and alkylated prod-
ucts are provided in the Supporting Information.
4.4. Representative procedure for alkylation with 2ꢀ alcohols:
synthesis of 3-cyclopropyl-1-(2,3,4,5,6-pentamethylphenyl)butan-
1-one (101)
4.2. Representative procedure for a-alkylation of cyclopropyl
ketones: synthesis of 2-butyl-1-cyclopropylhexan-1-one (8)
To a 2e5 mL Biotage® microwave vial equipped with a stirrer
bar was added 1-(2,3,4,5,6-pentamethylphenyl)ethan-1-one 83
(114 mg, 0.60 mmol), [Cp*IrCl2]2 (9.6 mg, 2.0 mol%), 1-
cyclopropylethan-1-ol (120 mg, 1.20 mmol), PhMe (0.15 mL) and
NaOtBu (173 mg, 1.80 mmol) sequentially in the open atmosphere.
The reaction vessel was sealed with a microwave vial cap (con-
taining a Reseal™ septum) and an Ar balloon fitted. The vial was
heated to 85 ꢀC in a preheated oil bath for 24 h. The mixture was
cooled to RT, filtered through a SiO2 plug (eluting with Et2O) and
concentrated in vacuo. Purification by column chromatography
(SiO2, eluent load, Pentane:Et2O, 98:2) afforded the title compound
101 (149 mg, 96%) as a colourless solid. Rf ¼ 0.38 (Pentane:Et2O,
95:5), [UV, KMnO4]; m.p. ¼ 46e47 ꢀC; IR (film) nmax/cmꢂ1 3077,
2998, 2988, 2955, 2928, 2910, 2873, 1700, 1574, 1459, 1427, 1401,
1383,1370,1350,1314,1300,1270, 1129,1095,1070,1045,1016, 999;
To a 2e5 mL Biotage® microwave vial equipped with a stirrer
bar was added 1-cyclopropylhexan-1-one (42.0 mg, 0.30 mmol),
[Cp*IrCl2]2 (4.8 mg, 2 mol%), KOH (50.5 mg, 0.90 mmol) and nBuOH
(0.14 mL, 1.50 mmol) sequentially in the open atmosphere. The
reaction vessel was sealed with a microwave vial cap (containing a
Reseal™ septum) and purged with Ar for 5 min using a balloon.
Following this, the vial (complete with an Ar balloon) was heated to
105 ꢀC in a preheated oil bath for 24 h. The mixture was cooled to
RT, filtered through a SiO2 plug (eluting with Et2O) and concen-
trated in vacuo. Purification by column chromatography (SiO2,
eluent load, Pentane:Et2O, 99:1) afforded the title compound 8
(38.0 mg, 65%) as a colorless oil. Rf ¼ 0.56 (Pentane:Et2O, 90:10),
[vanillin]; IR (film) nmax/cmꢂ1 3009, 2957, 2930, 2873, 2859, 1695,
1467, 1458, 1417, 1382, 1196, 1159, 1063, 1022, 997; 1H NMR (CDCl3,
1H NMR (CDCl3, 400 MHz)
d
¼ 2.88 (1H, dd, J ¼ 19.1, 4.2 Hz,
400 MHz)
propyl CH), 1.70e1.59 (2H, m, 2 ꢃ CHAHBCHCO), 1.49e1.39 (2H, m,
CHAHBCHCO), 1.35e1.17 (8H, m, CH2CH2CH3 and
d
¼ 2.59e2.50 (1H, m, CHCO), 1.99e1.92 (1H, m, cyclo-
CHAHBCO), 2.65 (1H, dd, J ¼ 19.1, 8.4 Hz, CHAHBCO), 2.23 (3H, s, Ar-
CH3), 2.19 (6H, s, 2 ꢃ Ar-CH3), 2.12 (6H, s, 2 ꢃ Ar-CH3), 1.54e1.41
(1H, m, CHCH2CO), 1.13 (3H, d, J ¼ 6.7 Hz, CH3), 0.69e0.58 (1H, m,
cyclopropyl CH), 0.49e0.36 (2H, m, cyclopropyl CAHAHB and
cyclopropyl CBHAHB), 0.23e0.12 (2H, m, cyclopropyl CAHAHB and
2
ꢃ
2
ꢃ
2 ꢃ CH2CH2CH3), 1.02e0.97 (2H, m, cyclopropyl CAHAHBCH and
cyclopropyl CBHAHBCH), 0.88 (6H, t, J ¼ 7.1 Hz, 2 ꢃ CH3), 0.86e0.81
(2H, m, cyclopropyl CAHAHBCH and cyclopropyl CBHAHBCH); 13C
cyclopropyl CBHAHB); 13C NMR (CDCl3, 101 MHz)
140.9 (AreC), 135.4 (AreC), 133.2 (2C, 2 ꢃ AreC), 127.4 (2C,
d
¼ 211.3 (C]O),
NMR (CDCl3, 101 MHz)
d
¼ 215.0 (C]O), 53.6 (CHCO), 31.7 (2C,
10